---
title: "VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297052582.md"
description: "VolitionRx has transferred its Nu.Q NETs assay to Sysmex’s platform, initiating discussions for a broader commercial agreement. This move facilitates potential deployment on Sysmex analyzers and enhances licensing prospects with major diagnostics groups. Additionally, VolitionRx reported active licensing talks with over a dozen global diagnostic and liquid biopsy companies."
datetime: "2026-08-26T13:17:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297052582.md)
  - [en](https://longbridge.com/en/news/297052582.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297052582.md)
generator: "portal-rs"
---

# VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platform

-   VolitionRx transferred its Nu.Q NETs assay onto Sysmex’s platform, setting up talks on a broader commercial agreement. \* Move positions the sepsis-focused test for potential deployment on Sysmex analyzers, strengthening licensing prospects with major diagnostics groups. \* Update also cited active licensing discussions with more than a dozen global diagnostic and liquid biopsy companies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VolitionRX Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608260917PR\_NEWS\_USPR\_\_\_\_\_LN34057) on August 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VNRX.US](https://longbridge.com/en/quote/VNRX.US.md)
- [SSMXY.US](https://longbridge.com/en/quote/SSMXY.US.md)
- [6869.JP](https://longbridge.com/en/quote/6869.JP.md)

## Related News & Research

- [VolitionRx issues 4,698,628 shares to Lind Global on note conversions under private placement exemption](https://longbridge.com/en/news/297766260.md)
- [Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake](https://longbridge.com/en/news/298078305.md)
- [VolitionRx secures lender waiver for above-cap ATM equity sales under convertible debt deal](https://longbridge.com/en/news/297829099.md)
- [Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations](https://longbridge.com/en/news/297180564.md)
- [Nu Holdings (NU) Could Be 36% Undervalued On Q1 Revenue Beat](https://longbridge.com/en/news/297678277.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**